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This work provides reagents to develop specific inhibitors of the macrodomains of PARP14, for 
potential use for cancer and/or inflammation. Targeting the macrodomains of PARP14 is an 
alternative targeting strategy to PARP catalytic domain inhibitors that may allow greater inhibitor 
selectivity, and an alternative cellular effect. 
This package includes protein purification protocols, crystal structures of the 2nd and 3rd 
macrodomain of PARP14 in complex with small molecule chemical starting points, in vitro assays to 
measure ligand binding to the macrodomains, as well as validation of a PARP14 antibody and 
reagents to generate PARP14 knock-out cell lines (CRISPR-Cas9). 
 
 
The Target Enabling Package (TEP) programme's foundation is built upon the recognition that 
genetic data is proving to be a powerful tool for target validation. As such, TEPs provide a critical 
mass of reagents and knowledge on a protein target to allow rapid biochemical and chemical 
exploration and characterisation of proteins with genetic linkage to key disease areas. TEPs provide 
an answer to the missing link between genomics and chemical biology, provide a starting point for 
chemical probe generation and therefore catalyse new biology and disease understanding with the 
ultimate aim of enabling translation collaborations and target/ drug discovery. 
 
 
 
Future versions of this document will contain experimental data about the FAM83B TEP.  
 
For more information regarding any aspect of TEPs and the TEP programmes, please contact 
teps@thesgc.org or visit https://thesgc.org/tep  
